The prophylactic effect of intravenous magnesium infusion on postoperative sore throat after thyroid surgery

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

PACTR

Registry ID

PACTR201810759555893

Enrollment

Registered

2018-10-22

Start date

2018-11-10

Completion date

Unknown

Last updated

2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anaesthesia

Interventions

Magnesium group

Control group

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Eligibility criteria for this study included female patients, with a ranging age of age > 20 and one hour

Exclusion criteria

Exclusion criteria: duration of surgery >3 hours, preexisting sore throat, corticosteroid use, or respiratory disease. pregnancy or breast feeding; body mass index > 30 kg/m2; significant heart, kidney, or liver disease; psychiatric or neurological disorders and hypersensitivity to magnesium

Design outcomes

Primary

Measure	Time frame
record the influence of perioperative magnesium adminstration on POST in thyroid surgery	—

Secondary

Measure	Time frame
Intraoperative analgesic consumption;Recovery profile ;Side effects as respiratory depression, emesis. hypotension, bradycardia;Postoperative pain	—

Countries

Egypt

Contacts

Public ContactRaham Hasan Mostafa

Lecturer of Anesthesia Ain Shams university

rahamhasan@yahoo.com20201222530020

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Feb 4, 2026